The Association Between Overweight and Oocyte Diameter in Women Undergoing Vitro Fertilization

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2012 by Hillel Yaffe Medical Center.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by (Responsible Party):
Hillel Yaffe Medical Center
ClinicalTrials.gov Identifier:
NCT01672931
First received: August 22, 2012
Last updated: NA
Last verified: August 2012
History: No changes posted
  Purpose

We believe that there is an association between BMI and oocyte diameter in women undergoing IVF treatments. We plan to measure the oocyte diameter in 2 groups of women undergoing IVF. One group will have BMI 20-25 and the other group will have BMI above 30.


Condition Intervention
Infertility
Obesity
Other: Oocyte Measurement

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by Hillel Yaffe Medical Center:

Primary Outcome Measures:
  • Larger Size of Oocyte Diameter [ Time Frame: One year ] [ Designated as safety issue: No ]
    Oocyte will be measured in women undergoing IVF treatment


Estimated Enrollment: 60
Study Start Date: September 2012
Estimated Study Completion Date: September 2013
Estimated Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
BMI over 30
Women undergoing IVF with BMI over 30
Other: Oocyte Measurement
BMI 20-25
Women undergoing IVF treatments with BMI between 20-25
Other: Oocyte Measurement

  Eligibility

Ages Eligible for Study:   18 Years to 45 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Women undergoing IVF treatments

Criteria

Inclusion Criteria:

  • IVF treated patients
  • BMI between 20-25 or over 30

Exclusion Criteria:

  • Everyone else
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01672931

Contacts
Contact: Gai Shrem, MD 972-50-6793080 gai.shrem@gmail.com

Locations
Israel
Hillel Yaffe Medical Center Not yet recruiting
Hadera, Israel, 38100
Sponsors and Collaborators
Hillel Yaffe Medical Center
Investigators
Principal Investigator: Gai Shrem, MD Hillel Yaffe Medical Center
  More Information

No publications provided

Responsible Party: Hillel Yaffe Medical Center
ClinicalTrials.gov Identifier: NCT01672931     History of Changes
Other Study ID Numbers: 0034-12 HYMC
Study First Received: August 22, 2012
Last Updated: August 22, 2012
Health Authority: Israel: Ministry of Health

Additional relevant MeSH terms:
Infertility
Genital Diseases, Male
Genital Diseases, Female

ClinicalTrials.gov processed this record on September 30, 2014